Barely Significant
← all excerpts

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada.

Am J Perinatol · 2022 · PMC9643049 · PMID 33657636

Europe PMCDOI
1
hedged sentence
0.0005
closest p · 0.0× alpha
0.0005
boldest claim

The sentences

highly significantp < 0.0005actually significant
The overall model was highly significant ( χ 2 [6] = 94.7, p < 0.0005).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.